title: A review of arsenic trioxide and acute promyelocytic leukemia.
abstract: Arsenic Trioxide is an old drug that has recently re- introduced into new medicine. It is very potent against a specific type of leukemic cells harboring translocation between chromosomes 15 and 17. It has been demonstrated that this drug is effective against all stages of acute promyelocytic leukemia, including for remission induction of relapsed cases, or as first-line treatment. It is also useful in the consolidation/maintenance phase of treatment. Many trials are ongoing to determine the best and optimum schedule for this drug as a single agent or in combination with other drugs. In the future, its indications might extend to other malignancies. In this review, we will study biologic effects of arsenic trioxide on APL cells and the results of clinical trials on the treatment of APL. We will also discuss the toxicity and minimal residual detection during patient follow-up.
authors: Professor of medicine, research institute for oncology hematology and stem cell transplantation, Tehran University of Medical Sciences, Shariati Hospital, Kargar Ave. Tehran, 14114, IRAN.
authors: Kamran
authors: K
authors: Alimoghaddam
keywords: APL; Arsenic Trioxide; Biology and treatment
references: Chin Med J (Engl). 2000 Oct;113(10):899-902
references: 11775836
references: Leukemia. 2005 Aug;19(8):1306-11
references: 15920495
references: Biochem Biophys Res Commun. 2001 Aug 31;286(4):726-34
references: 11520058
references: Leukemia. 1995 Apr;9(4):588-93
references: 7723389
references: Ann Oncol. 2003 May;14(5):752-7
references: 12702530
references: Zhonghua Yi Xue Za Zhi. 2000 May;80(5):327-31
references: 11798779
references: Br J Haematol. 2001 Oct;115(1):63-5
references: 11722411
references: Int J Hematol. 2005 Oct;82(3):224-9
references: 16207595
references: Ann Oncol. 2006 Jan;17(1):131-4
references: 16227315
references: J Clin Oncol. 2003 Jun 15;21(12):2326-34
references: 12805334
references: Blood. 1993 Dec 15;82(12):3556-9
references: 8260693
references: Blood. 1999 Jan 1;93(1):268-77
references: 9864170
references: J Clin Oncol. 1998 Jan;16(1):78-85
references: 9440726
references: Haematologica. 2007 Mar;92(3):315-22
references: 17339180
references: Semin Thromb Hemost. 2007 Jun;33(4):330-8
references: 17525890
references: Leukemia. 2005 Oct;19(10):1806-11
references: 16107885
references: Blood. 1999 Nov 15;94(10):3315-24
references: 10552940
references: Int J Hematol. 2006 May;83(4):337-40
references: 16757435
references: Hematology Am Soc Hematol Educ Program. 2006;:156-61, 514
references: 17124055
references: Arch Iran Med. 2011 Sep;14(5):332-4
references: 21888457
references: Zhonghua Yi Xue Za Zhi. 2005 Apr 27;85(16):1093-6
references: 16029564
references: Blood. 1996 Aug 1;88(3):1052-61
references: 8704214
references: Mol Biol Cell. 2010 Dec;21(23 ):4227-39
references: 20943951
references: Haematologica. 2001 Jun;86(6):577-85
references: 11418366
references: Blood. 2002 Dec 15;100(13):4298-302
references: 12393590
references: J Clin Oncol. 2001 Sep 15;19(18):3852-60
references: 11559723
references: Leukemia. 2000 Oct;14(10):1743-50
references: 11021749
references: Arch Iran Med. 2011 May;14(3):167-9
references: 21529103
references: Leukemia. 2000 Feb;14 (2):262-70
references: 10673743
references: Int J Hematol. 1999 Dec;70(4):248-60
references: 10643151
references: Best Pract Res Clin Haematol. 2003 Sep;16(3):419-32
references: 12935960
references: Leuk Lymphoma. 2006 Aug;47(8):1629-38
references: 16966277
references: Leukemia. 2007 Jul;21(7):1488-95
references: 17495969
references: Int J Oncol. 2002 Jul;21(1):57-63
references: 12063550
references: Ann Hematol. 2013 Sep;92(9):1207-20
references: 23645216
references: Blood. 2012 Aug 23;120(8):1570-80; quiz 1752
references: 22715121
references: Oncol Rep. 2003 May-Jun;10(3):705-9
references: 12684647
references: Blood. 2011 Aug 4;118(5):1248-54
references: 21653939
references: Zhonghua Xue Ye Xue Za Zhi. 2003 Jan;24(1):25-7
references: 12679006
references: Blood. 2004 May 1;103(9):3496-502
references: 14701702
references: Leukemia. 2003 Jul;17(7):1333-7
references: 12835721
references: Chin Med J (Engl). 1996 Apr;109 (4):295-9
references: 8758291
references: Blood. 2013 Mar 14;121(11):1935-43
references: 23319575
references: J Biol Chem. 2006 Sep 29;281(39):28764-71
references: 16891316
references: Haematologica. 2007 Oct;92(10):1431-2
references: 18024380
references: Blood. 2014 May 1;123(18):2777-82
references: 24627526
references: Blood. 1999 Oct 15;94(8):2844-53
references: 10515888
references: Pharmacol Ther. 1997 Oct-Dec;76(1-3):141-9
references: 9535176
references: Haematologica. 2007 Jun;92(6):753-62
references: 17550847
references: Ann Oncol. 2008 Nov;19(11):1927-34
references: 18567608
references: J Clin Oncol. 2011 Jul 10;29(20):2753-7
references: 21646615
references: Am J Hematol. 2001 Apr;66(4):274-9
references: 11279639
references: Leuk Lymphoma. 2006 Jan;47(1):81-8
references: 16321832
references: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35
references: 15044693
references: J Clin Oncol. 2000 Jul;18(13):2620-5
references: 10893295
references: J Clin Oncol. 2009 Feb 1;27(4):504-10
references: 19075265
references: Chin Med J (Engl). 2001 Jan;114(1):30-4
references: 11779431
references: Cancer. 2007 Apr 1;109 (7):1355-9
references: 17326049
references: Blood. 2006 Apr 1;107(7):2627-32
references: 16352810
references: Zhonghua Xue Ye Xue Za Zhi. 2003 Jan;24(1):32-4
references: 12679008
references: Leukemia. 2000 Jun;14(6):1006-13
references: 10865965
references: Leuk Lymphoma. 2004 Mar;45(3):469-80
references: 15160908
references: Zhonghua Nei Ke Za Zhi. 2001 Jan;40(1):36-9
references: 11798557
references: Blood. 2006 May 1;107(9):3469-73
references: 16373661
references: Haematologica. 2012 Jan;97(1):133-6
references: 21993679
references: Leukemia. 1998 Sep;12(9):1349-54
references: 9737682
references: Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2000 Sep;8(3):180-184
references: 12578678
references: Leuk Res. 2007 Nov;31(11):1585-7
references: 17416415
references: N Engl J Med. 1998 Nov 5;339(19):1341-8
references: 9801394
references: Free Radic Biol Med. 2003 Mar 1;34(5):598-606
references: 12614848
references: J Clin Oncol. 2010 Aug 20;28(24):3866-71
references: 20644086
references: Leuk Res. 2007 Jun;31(6):765-71
references: 17007927
references: Best Pract Res Clin Haematol. 2002 Mar;15(1):137-58
references: 11987921
references: Blood. 2000 Aug 15;96(4):1247-53
references: 10942364
references: Blood. 1999 Sep 15;94(6):2102-11
references: 10477740
references: Ann Oncol. 2006 Oct;17(10):1553-9
references: 16831853
references: Hematol Oncol. 2004 Jun;22(2):63-71
references: 15468344
references: Nat Genet. 1998 Nov;20(3):259-65
references: 9806544
references: Blood. 1997 May 1;89(9):3354-60
references: 9129042
references: Beijing Da Xue Xue Bao. 2006 Jun 18;38(3):236-8
references: 16778962
references: Am J Hematol. 2006 Sep;81(9):720
references: 16804937
references: Med Oncol. 2000 Nov;17(4):307-13
references: 11114710
references: Zhonghua Nei Ke Za Zhi. 2001 Dec;40(12):829-33
references: 16206674
references: Leuk Res. 2007 May;31(5):703-5
references: 16876245
references: Leukemia. 1994 Apr;8 Suppl 1:S116-20
references: 8152276
references: Blood. 2001 Jul 15;98(2):266-71
references: 11435292
references: Leukemia. 2001 Jul;15(7):1060-5
references: 11455974
references: Haematologica. 2007 Jul;92(7):994-5
references: 17606455
references: Br J Haematol. 2002 Apr;117(1):130-2
references: 11918543
references: Clin Adv Hematol Oncol. 2006 Jan;4(1):57-62, 76-7
references: 16562371
references: Int J Hematol. 2002 Aug;76 Suppl 2:179-87
references: 12430923
references: N Engl J Med. 2013 Jul 11;369(2):111-21
references: 23841729